The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer
Ciara C. O’Sullivan(Mayo Clinic in Arizona), Tito Fojo(James J. Peters VA Medical Center)
Cited by 98
Related Papers
Combination Chemotherapy in Advanced Adrenocortical Carcinoma
|New England Journal of Medicine|2012|863
Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity
|JAMA Otolaryngology–Head & Neck Surgery|2014|301
Lessons from withdrawn accelerated approvals in oncology
|Nature Cancer|2024|11